This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barnes, E. Articles by Camici, P. G. Search for Related Content PubMed PubMed Citation Articles by Barnes, E. Articles by Camici, P. G.

CLINICAL STUDY: MYOCARDIAL ISCHEMIA

Absolute blood flow and oxygenconsumption in stunned myocardiumin patients with coronary artery disease

^* MRC Clinical Sciences Centre and Division of Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

Manuscript received May 14, 2001; revised manuscript received October 19, 2001, accepted November 2, 2001.

^* Reprint requests and correspondence: Prof. Paolo Camici, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, England W12 0NN, United Kingdom.
paolo.camici{at}csc.mrc.ac.uk

OBJECTIVES: In patients with coronary artery disease (CAD), we sought to demonstrate normal myocardial blood flow (MBF) and myocardial oxygen consumption (MMRO₂) to post-ischemic myocardium that exhibited reversible dysfunction and the relation between the severity of the dysfunction and the preceding ischemia.

BACKGROUND: In animal models of stunning, MBF and MMRO₂ are normal or near normal, and the severity of stunning is related to the degree of the preceding ischemia.

METHODS: Myocardial blood flow and MMRO₂ were measured using positron emission tomography and oxygen 15-labelled water (H₂¹⁵O) and oxygen 15-labelled oxygen (¹⁵O₂), respectively, in 14 patients with CAD and normal left ventricular (LV) function. Global ejection fraction and regional LV systolic function (SF) were measured using quantitative echocardiography during and after dobutamine-induced ischemia.

RESULTS: Ejection fraction and SF were reduced 30 min after dobutamine (both: p < 0.01) but recovered by 120 min. Myocardial blood flow (ml/min per g) to regions with reversible LV dysfunction was normal at baseline and during dysfunction (0.88 [0.82 to 0.99] and 1.09 [0.75 to 1.37], respectively, p = NS) as was MMRO₂ (ml/min per 100 g) (16.64 [10.16 to 16.18] and 11.68 [8.43 to 15.30] respectively, p = NS). Left ventricular dysfunction was related to stenosis severity and peak MBF. Regions were divided into those subtended by a stenosis of <50%, 50% to 80% and >80% luminal diameter. Systolic function 30 min after dobutamine was 93.9% (83.4% to 104.4%) (p = NS), 85.4% (80.0% to 90.9%) and 67.4% (56.2% to 78.7%) (both: p < 0.001), respectively. Peak MBF was 2.0 (1.71 to 2.31), 1.75 (1.65 to 1.85) (p = 0.01 compared with <50%) and 1.47 (1.33 to 1.60) (p = 0.03 compared with 50% to 80% and p = 0.002 compared with <50%), respectively.

CONCLUSIONS: In patients with CAD, dobutamine produces prolonged, but reversible, LV dysfunction when MBF is normal, confirming stunning. This stunning is related to the severity of the coronary stenosis and the reduction in peak MBF. Myocardial oxygen consumption to stunned myocardium is normal.

Abbreviations and Acronyms   AP2CH   apical two-chamber   AP4CH   apical four-chamber   CAD   coronary artery disease   C15O   oxygen 15-labelled carbon monoxide   EF   ejection fraction   H215O   oxygen 15-labelled water   LV   left ventricular   MBF   myocardial blood flow   MMRO2   myocardial oxygen consumption   PET   positron emission tomography   RPP   rate pressure product   SBP   systolic blood pressure   SF   shortening fraction   SFnorm   regions not demonstrating post-ischemic dysfunction   SFdysfunction   regions demonstrating post-ischemic dysfunction   SPECT   single photon emission computed tomography   15O2   oxygen 15-labelled oxygen

This article has been cited by other articles:

				F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza CHAPTER 17 Chronic Ischaemic Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				C. W. McIntyre, J. O. Burton, N. M. Selby, L. Leccisotti, S. Korsheed, C. S.R. Baker, and P. G. Camici Hemodialysis-Induced Cardiac Dysfunction Is Associated with an Acute Reduction in Global and Segmental Myocardial Blood Flow Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 19 - 26. [Abstract] [Full Text] [PDF]

				P. G. Camici, S. K. Prasad, and O. E. Rimoldi Stunning, Hibernation, and Assessment of Myocardial Viability Circulation, January 1, 2008; 117(1): 103 - 114. [Full Text] [PDF]

				P. Knaapen, T. Germans, J. Knuuti, W. J. Paulus, P. A. Dijkmans, C. P. Allaart, A. A. Lammertsma, and F. C. Visser Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach Circulation, February 20, 2007; 115(7): 918 - 927. [Full Text] [PDF]

				V. D. Kakhki, S. R. Zakavi, R. Sadeghi, and A. Yousefi Importance of Gated Imaging in Both Phases of Myocardial Perfusion SPECT: Myocardial Stunning After Dipyridamole Infusion. J. Nucl. Med. Technol., June 1, 2006; 34(2): 88 - 91. [Abstract] [Full Text] [PDF]

				R. Senior, R. Janardhanan, P. Jeetley, and L. Burden Myocardial Contrast Echocardiography for Distinguishing Ischemic From Nonischemic First-Onset Acute Heart Failure: Insights Into the Mechanism of Acute Heart Failure Circulation, September 13, 2005; 112(11): 1587 - 1593. [Abstract] [Full Text] [PDF]

				S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology Eur. Heart J., May 2, 2004; 25(10): 815 - 836. [Abstract] [Full Text] [PDF]

				P G Camici Hibernation and heart failure Heart, February 1, 2004; 90(2): 141 - 143. [Full Text] [PDF]

				P. G Camici and O. E Rimoldi Myocardial blood flow in patients with hibernating myocardium Cardiovasc Res, February 1, 2003; 57(2): 302 - 311. [Abstract] [Full Text] [PDF]

				W. D. Foltz, H. Huang, S. Fort, and G. A. Wright Vasodilator Response Assessment in Porcine Myocardium With Magnetic Resonance Relaxometry Circulation, November 19, 2002; 106(21): 2714 - 2719. [Abstract] [Full Text] [PDF]